Realbotix Corp. XBOTF
—
0.19
0.00
0.00%
as of 25 Sep
- Market cap
- —
- P/E
- 0.0×
Follow XBOTF
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
36.45 | 43.93 | 43.88 | 70.85 | |
P/FCF ratio |
43.74 | 33.32 | 24.36 | 76.22 | |
P/Operating CF |
(33.24) | (54.56) | (36.42) | (29.09) | |
P/B ratio |
20.04 | 8.82 | 5.54 | 8.64 | |
Price to Tangible BV |
28.26 | 10.09 | 6.19 | 9.86 | |
EV/Sales |
34.39 | 39.20 | 38.06 | 64.98 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(12.78) | (12.03) | (7.77) | (7.85) | |
EV/FCF |
41.26 | 29.73 | 21.13 | 69.90 | |
Quick Ratio |
2.22 | 5.48 | 5.43 | 6.07 | |
Current Ratio |
2.43 | 5.86 | 5.80 | 6.72 | |
Net Debt/EBITDA |
1.80 | 5.19 | (10.89) | 3.04 | |
Debt/Assets |
14.59% | 0.11% | 0.00% | 5.53% | |
Debt/Equity |
0.28 | 0.00 | 0.00 | 0.07 | |
Asset Turnover |
0.21 | 0.14 | 0.12 | 0.10 | |
Operating CF/Net income |
2.52 | 0.93 | (3.26) | 1.09 | |
Capex/Depreciation |
0.00 | 0.00 | 0.67 | 9.78 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
(439.06%) | 35.30% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
(786.20%) | 255.33% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.15 | 0.11 | 0.09 | 0.10 | |
Share Based Compensation of Revenue |
49.23% | 94.33% | 115.41% | 9.15% | |
Graham Net Nets |
0.03 | 0.10 | 0.16 | 0.09 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(6.73%) | (10.91%) | (6.14%) | (7.92%) | |
Free Cash Flow Yield |
2.29% | 3.00% | 4.10% | 1.31% | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.01) | (0.01) | (0.01) | (0.01) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.01 | |
Free Cash Flow per Share |
(0.01) | (0.01) | (0.01) | 0.00 | |
Cash per Share |
0.03 | 0.03 | 0.03 | 0.02 | |
Shareholders Equity per Share |
0.02 | 0.04 | 0.04 | 0.03 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.02 | 0.04 | 0.04 | 0.03 | |
Free Cash Flow |
(2.21) | (1.25) | (1.16) | (0.47) | |
Working Capital |
3.41 | 6.61 | 7.33 | 5.51 | |
Capital Expenditures |
— | — | 0.10 | 1.50 | |
Net Current Asset Value |
2.38 | 6.60 | 7.33 | 5.07 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | (0.44) | (4.23) | |
Net Profit Margin |
707.67% | (380.40%) | 171.94% | (511.55%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.09 | 0.07 | 1.15 | 0.52 | |
Average Payables |
0.51 | 0.62 | 0.77 | 0.46 | |
Average Inventory |
0.38 | 0.34 | 0.41 | 0.39 | |
Average Assets |
9.65 | 10.92 | 8.71 | 7.77 | |
Average Common Equity |
5.84 | 8.40 | 6.31 | 5.69 |
Columns are period end dates · fundamentals updated 24 Sep 2026